They have a Letter of "Intent" with Khon Kaen University in which *I* have not been able to verify with the University. Furthermore, those clinical trials with the University have not even started or stated a date in which they would start. AML trials would be huge news. And you don't know what I own, I'm pretty sure that I have never told you the diversification of my portfolio. However, I AM an investor and not paid to promote.
All stocks, are based upon a product or promise of a product.
This "fast talk" and throwing around jargon can go so far, but the proof is in the pudding. Look at the dilution, look at the outstanding shares, look at the price of the stock, look at the lack of transparency. But why am I telling you this, you already know what it is.